http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EA-200100105-A1

Outgoing Links

Predicate Object
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P7-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D417-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D413-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D277-24
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D263-32
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D413-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D417-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4439
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-422
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-421
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-427
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-426
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D277-22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-497
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-496
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D277-24
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D263-32
filingDate 1999-08-05-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 2001-08-27-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber EA-200100105-A1
titleOfInvention SUBSTITUTED DERIVATIVES OF OXAZOLES AND THIAZOLES AS ACTIVATORS OF hPPAR GAMMA and hPPAR ALPHA
abstract The present compound discloses compounds of formula (I) and their tautomeric forms, pharmaceutically acceptable salts or solvates. Preferably, the compounds of this invention are dual activators hPPARγ and hPPARα. The international application was published along with an international search report.
priorityDate 1998-08-07-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID19013
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419533341
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID458910
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID281992
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID557714
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID5465
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID374120
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID9256
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID25747
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID403654

Total number of triples: 45.